The pathophysiology of Parkinson's disease is now well understood and several pharmaceutical agents offer good symptomatic relief. However the relative frequency of occurrence in the elderly, the distressing nature of the symptoms and the common side-effects of drug treatment make the disease a major challenge for all neurologists. In addition, the continuing hold that an effective "cure" is close at hand will ensure that the disease remains a centre of neurological interest.
Reihe
Sprache
Verlagsort
Verlagsgruppe
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Illustrationen
Maße
Höhe: 162 mm
Breite: 241 mm
Gewicht
ISBN-13
978-0-340-51768-0 (9780340517680)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Autor*in
all of Oregon Health Science University, USA
Introduction and epidemiology; diagnosis - is it Parkinsonism? - major symptoms and signs of the disorder; diagnosis - less common features and pitfalls; diagnosis - what is the cause of Parkinsonism?; drug therapy - general principles; drug therapy - protective therapy; therapy - non-dopaminergic agents; therapy - levodopa in early stages of Parkinsonism; therapy - levodopa in later stages of the diesease; therapy - dopamine agonists; non-pharmacological interventions; affective, cognitive and sleep disturbances; autonomic and vegetative functions; special considerations; future therapies.
